資料載入中.....
|
請使用永久網址來引用或連結此文件:
https://ir.cnu.edu.tw/handle/310902800/31685
|
| 標題: | High Expression of EphA4 Predicted Lesser Degree of Tumor Regression after Neoadjuvant Chemoradiotherapy in Rectal Cancer |
| 作者: | Lin, Ching-Yih
Lee, Ying-En
Tian, Yu-Feng
Sun, Ding-Ping
Sheu, Ming-Jen
Lin, Chen-Yi
Li, Chien-Feng
Lee, Sung-Wei
Lin, Li-Ching
Chang, I-Wei
Wang, Chieh-Tien
He, Hong-Lin |
| 貢獻者: | Chi Mei Med Ctr, Div Gastroenterol & Hepatol, Dept Internal Med
Southern Taiwan Univ Sci & Technol, Dept Leisure Recreat & Tourism Management
KaohsiungChang Gung Mem Hosp, Dept Anesthesiol
Chang Gung Univ, Coll Med
Chi Mei Med Ctr, Div Gen Surg, Dept Surg
Chia Nan Univ Pharm & Sci, Dept Hlth & Nutr
Chia Nan Univ Pharm & Sci, Dept Pharm
Chi Mei Med Ctr, Dept Pathol
Natl Hlth Res Inst, Natl Inst Canc Res
Southern Taiwan Univ Sci & Technol, Dept Biotechnol
Kaohsiung Med Univ, Inst Clin Med
Chi Mei Med Ctr, Dept Radiat Oncol
I Shou Univ, E DA Hosp, Dept Pathol
Chi Mei Med Ctr, Dept Pathol
Chung Hwa Univ Med Technol, Dept Med Lab Sci & Biotechnol
Natl Sun Yat Sen Univ, Inst Biomed Sci |
| 關鍵字: | EphA4
rectal cancer
chemoradiotherapy
CCRT |
| 日期: | 2017 |
| 上傳時間: | 2018-11-30 15:52:49 (UTC+8) |
| 出版者: | Ivyspring Int Publ |
| 摘要: | Background: Numerous transmembrane receptor tyrosine kinase pathways have been found to play an important role in tumor progression in some cancers. This study was aimed to evaluate the clinical impact of Eph receptor A4 (EphA4) in patients with rectal cancer treated with neoadjuvant concurrent chemoradiotherapy (CCRT) combined with mesorectal excision, with special emphasis on tumor regression. Methods: Analysis of the publicly available expression profiling dataset of rectal cancer disclosed that EphA4 was the top-ranking, significantly upregulated, transmembrane receptor tyrosine kinase pathway-associated gene in the non-responders to CCRT, compared with the responders. Immunohistochemical study was conducted to assess the EphA4 expression in pre-treatment biopsy specimens from 172 rectal cancer patients without distant metastasis. The relationships between EphA4 expression and various clinicopathological factors or survival were statistically analyzed. Results: EphA4 expression was significantly associated with vascular invasion (P=0.015), post-treatment depth of tumor invasion (P=0.006), pre-treatment and post-treatment lymph node metastasis (P=0.004 and P=0.011, respectively). More importantly, high EphA4 expression was significantly predictive for lesser degree of tumor regression after CCRT (P=0.031). At univariate analysis, high EphA4 expression was a negative prognosticator for disease-specific survival (P=0.0009) and metastasis-free survival (P=0.0001). At multivariate analysis, high expression of EphA4 still served as an independent adverse prognostic factor for disease-specific survival (HR, 2.528; 95% CI, 1.131-5.651; P=0.024) and metastasis-free survival (HR, 3.908; 95% CI, 1.590-9.601; P=0.003). Conclusion: High expression of EphA4 predicted lesser degree of tumor regression after CCRT and served as an independent negative prognostic factor in patients with rectal cancer. |
| 關聯: | Journal of Cancer, v.8, n.6, pp.1089-1096 |
| 顯示於類別: | [藥學系(所)] 期刊論文
|
文件中的檔案:
| 檔案 |
描述 |
大小 | 格式 | 瀏覽次數 |
|---|
| index.html | | 0Kb | HTML | 1288 | 檢視/開啟 | | jca.17471.pdf | | 1162Kb | Adobe PDF | 0 | 檢視/開啟 |
|
在CNU IR中所有的資料項目都受到原著作權保護.
|
